| 1 | [SID144204122] | Active | Potency | 0.057 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 144204122 | | CID | 26596 | | Outcome | Active | | Potency | 0.057 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID144204122] | Active | Potency | 0.057 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 144204122 | | CID | 26596 | | Outcome | Active | | Potency | 0.057 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID144204122] | Active | Potency | 0.057 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 144204122 | | CID | 26596 | | Outcome | Active | | Potency | 0.057 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID144204122] | Active | Potency | 0.0718 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 144204122 | | CID | 26596 | | Outcome | Active | | Potency | 0.0718 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID144204122] | Active | Potency | 0.0718 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 144204122 | | CID | 26596 | | Outcome | Active | | Potency | 0.0718 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID144204122] | Active | Potency | 0.0718 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 144204122 | | CID | 26596 | | Outcome | Active | | Potency | 0.0718 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID11112614] | Active | Potency | 0.1276 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | Potency | 0.1276 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 8 | [SID11112614] | Active | Potency | 0.2389 | S16 Schwann cell PMP22 intronic element beta-lactamase assay [AID624044, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | Potency | 0.2389 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element beta-lactamase assay | | AID | 624044 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 9 | [SID49699301] | Active | | | Vibrio cholerae assay for pro-quorum sensing small molecules [AID686977, Type: screening] | cyclic AMP receptor protein [Vibrio cholerae O1 biovar El Tor str. N16961] [gi:9657203] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49699301 | | CID | 26596 | | Outcome | Active | | BioAssay | Vibrio cholerae assay for pro-quorum sensing small molecules | | AID | 686977 | | BioAssay type | screening | | Target | cyclic AMP receptor protein [Vibrio cholerae O1 biovar El Tor str. N16961] [gi:9657203] | | PubMed | | | Data Table |  |
|
| 10 | [SID85860907] | Active | | | Inhibition of P. falciparum 3D7 [AID2306, Type: screening] | L-lactate dehydrogenase [Plasmodium falciparum 3D7] [gi:124513266] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85860907 | | CID | 26596 | | Outcome | Active | | BioAssay | Inhibition of P. falciparum 3D7 | | AID | 2306 | | BioAssay type | screening | | Target | L-lactate dehydrogenase [Plasmodium falciparum 3D7] [gi:124513266] | | PubMed | | | Data Table |  |
|
| 11 | [SID85788909] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 [AID2330, Type: screening] | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | | AID | 2330 | | BioAssay type | screening | | Target | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] | | PubMed | | | Data Table |  |
|
| 12 | [SID85788909] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 [AID2330, Type: screening] | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | | AID | 2330 | | BioAssay type | screening | | Target | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] | | PubMed | | | Data Table |  |
|
| 13 | [SID85788909] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 [AID2330, Type: screening] | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | | AID | 2330 | | BioAssay type | screening | | Target | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] | | PubMed | | | Data Table |  |
|
| 14 | [SID11112614] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 15 | [SID11112614] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 16 | [SID11112614] | Active | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 17 | [SID11112614] | Active | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 18 | [SID11112614] | Active | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 19 | [SID11112614] | Active | | | GR-GFP Redistribution [AID450, Type: confirmatory] | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | GR-GFP Redistribution | | AID | 450 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor isoform gamma [Homo sapiens] [gi:66528677] | | PubMed | | | Data Table |  |
|
| 20 | [SID138433] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice [AID200, Type: other] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 138433 | | CID | 26596 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice | | AID | 200 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID138433] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 [AID220, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 138433 | | CID | 26596 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 | | AID | 220 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID138433] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 138433 | | CID | 26596 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID138433] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 138433 | | CID | 26596 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID138433] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID328, Type: other] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 138433 | | CID | 26596 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 328 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID11112614] | Active | | | qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region [AID589, Type: other] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region | | AID | 589 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID11112614] | Active | | | qHTS Assay for Spectroscopic Profiling in A350 Spectral Region [AID590, Type: other] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in A350 Spectral Region | | AID | 590 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID11112614] | Active | | | Cell signaling CRE-BLA (Fsk stim) [AID662, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | Cell signaling CRE-BLA (Fsk stim) | | AID | 662 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID85788909] | Active | | | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells [AID2275, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells | | AID | 2275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID11112614] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 30 | [SID11112614] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 31 | [SID11112614] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 32 | [SID85860907] | Unspecified | XC50_3D7 | 0.68 | XC50 for P. falciparum 3D7 [AID2305, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85860907 | | CID | 26596 | | Outcome | Unspecified | | XC50_3D7 | 0.68 [uM] | | BioAssay | XC50 for P. falciparum 3D7 | | AID | 2305 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID85860907] | Unspecified | | | Inhibition Frequency Index [AID2297, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85860907 | | CID | 26596 | | Outcome | Unspecified | | BioAssay | Inhibition Frequency Index | | AID | 2297 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID11112614] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 35 | [SID11112614] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 36 | [SID11112614] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 37 | [SID11112614] | Inactive | Potency | 0.1 | qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Inactive | | Potency | 0.1 [uM] | | BioAssay | qHTS Assay for Compounds that Induce Erasure of Genomic Imprints | | AID | 1948 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID11112614] | Inactive | Potency | 1.0182 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Inactive | | Potency | 1.0182 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID11112614] | Inactive | Potency | 1.5472 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Inactive | | Potency | 1.5472 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 40 | [SID11112614] | Inactive | Potency | 1.8106 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Inactive | | Potency | 1.8106 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID85788909] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway [AID2313, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway | | AID | 2313 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID85788909] | Inactive | | | Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity [AID2322, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Inactive | | BioAssay | Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity | | AID | 2322 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID49699301] | Inactive | | | High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv [AID1332, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49699301 | | CID | 26596 | | Outcome | Inactive | | BioAssay | High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv | | AID | 1332 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID85788909] | Inactive | | | Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression [AID434959, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression | | AID | 434959 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID85860907] | Inactive | | | Inhibition of HepG2 cell line [AID2303, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85860907 | | CID | 26596 | | Outcome | Inactive | | BioAssay | Inhibition of HepG2 cell line | | AID | 2303 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID11112614] | Inactive | Potency | | S16 Schwann cell viability assay (CellTiter-Glo assay) [AID624031, Type: confirmatory] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | S16 Schwann cell viability assay (CellTiter-Glo assay) | | AID | 624031 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID85788909] | Inactive | | | Fluorescence Cell-Based Primary HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity [AID624156, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85788909 | | CID | 26596 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity | | AID | 624156 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID103914649] | Inactive | | | Screening small molecules to find regulators of human embryonic stem cell survival. [AID493140, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103914649 | | CID | 26596 | | Outcome | Inactive | | BioAssay | Screening small molecules to find regulators of human embryonic stem cell survival. | | AID | 493140 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID121363737] | Inactive | | | A screen for compounds that inhibit liver stage malaria [AID624349, Type: other] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 121363737 | | CID | 26596 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit liver stage malaria | | AID | 624349 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID11112614] | Inactive | Potency | | qHTS Assay for Inhibitors of Firefly Luciferase [AID411, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 11112614 | | CID | 26596 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Firefly Luciferase | | AID | 411 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|